[Hub]/) : Traits : Arm fat-free mass (left) : ← →

chr9:126,321,003-128,824,378

Best TWAS P=6.32e-10 · Best GWAS P=1.12e-09 conditioned to 1

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
14	GTEx	Thyroid	GAPVD1	0.05	0.05	enet	13	0.01	6.6e-02	-6.0	-6.2	6.3e-10	0.96	0.02	0.98	TRUE
1	GTEx	Adipose Subcutaneous	PSMB7	0.08	0.04	lasso	6	0.04	3.4e-04	4.4	-5.5	4.4e-08	0.02	0.02	0.97	TRUE
3	GTEx	Artery Tibial	GAPVD1	0.11	0.16	enet	19	0.16	6.4e-13	-5.7	-6.2	6.4e-10	0.94	0.02	0.98	FALSE
15	The Cancer Genome Atlas	Prostate Adenocarcinoma	GAPVD1	0.02	0.04	enet	4	0.01	9.8e-03	-6.1	6.1	9.9e-10	-0.97	0.02	0.90	FALSE
11	GTEx	Muscle Skeletal	GAPVD1	0.13	0.10	lasso	3	0.09	4.7e-09	-6.0	6.1	1.4e-09	-0.95	0.02	0.98	FALSE
12	GTEx	Nerve Tibial	GAPVD1	0.17	0.08	lasso	10	0.10	9.3e-08	5.0	-6.0	2.2e-09	0.84	0.13	0.87	FALSE
10	GTEx	Esophagus Muscularis	OLFML2A	0.08	0.00	enet	27	0.00	4.9e-01	4.8	5.5	3.4e-08	-0.50	0.08	0.23	FALSE
5	GTEx	Breast Mammary Tissue	PSMB7	0.11	0.03	lasso	7	0.04	4.7e-03	5.6	-5.5	4.4e-08	0.06	0.04	0.85	FALSE
7	GTEx	Colon Sigmoid	PSMB7	0.15	0.10	lasso	3	0.09	3.3e-04	5.3	-5.4	6.1e-08	0.05	0.04	0.92	FALSE
17	The Cancer Genome Atlas	Thyroid Carcinoma	PSMB7	0.06	0.06	lasso	4	0.04	3.7e-05	5.4	-5.4	6.1e-08	0.07	0.07	0.93	FALSE
16	The Cancer Genome Atlas	Prostate Adenocarcinoma	PSMB7	0.03	0.04	lasso	4	0.04	1.2e-04	5.3	-5.4	8.4e-08	0.03	0.03	0.93	FALSE
6	GTEx	Breast Mammary Tissue (Female)	PPP6C	0.14	0.04	lasso	4	0.04	3.1e-02	5.0	-5.3	1.2e-07	0.74	0.08	0.80	FALSE
4	GTEx	Brain Cerebellum	PRPS1P2	0.09	0.08	enet	16	0.04	2.8e-02	-6.0	5.3	1.3e-07	-0.84	0.05	0.79	FALSE
9	GTEx	Esophagus Mucosa	PRPS1P2	0.07	0.08	lasso	3	0.07	1.5e-05	5.0	5.2	1.7e-07	-0.67	0.47	0.45	FALSE
2	GTEx	Artery Aorta	PSMB7	0.15	0.03	enet	16	0.05	1.4e-03	-4.3	-5.2	1.9e-07	0.14	0.06	0.72	FALSE
13	GTEx	Thyroid	NEK6	0.20	0.21	lasso	4	0.20	1.3e-15	5.0	-5.2	2.1e-07	0.05	0.42	0.58	FALSE
8	GTEx	Esophagus Mucosa	PPP6C	0.07	0.07	enet	21	0.08	7.1e-06	5.0	-5.2	2.4e-07	0.67	0.85	0.14	FALSE